NLM Logo

APEL protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
APEL protocol
Unique ID
C045350
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C045350
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Doxorubicin
Vindesine
Frequency
3
Note
combination chemotherapy consisting of vindesine, cisplatin, doxorubicin; used in treatment of soft tissue sarcoma
Source
Presse Med 1985;14(19):1069
Date of Entry
1985/07/17
Revision Date
2000/11/30
APEL protocol Preferred
page delivered in 0.005s